IRVING, Texas, March 18, 2025--(BUSINESS WIRE)--biote Corp. (NASDAQ: BTMD) ("Biote" or the "Company") a leading solutions provider in preventive health care through the delivery of personalized ...

biote Corp. (NASDAQ: BTMD) (“Biote” or the “Company”) a leading solutions provider in preventive health care through the delivery of personalized hormone optimization and therapeutic ...

Investors who take an interest in biote Corp. (NASDAQ:BTMD) should definitely note that the Executive Chairman, Marc Beer, recently paid US$3.87 per share to buy US$417k worth of the stock.

biote Corp. (NASDAQ:BTMD) Q4 2024 Earnings Call Transcript March 12, 2025 biote Corp. beats earnings expectations. Reported ...

biote Corp. (NASDAQ:BTMD – Free Report) – Investment analysts at B. Riley issued their Q1 2025 earnings per share estimates for shares of biote in a research note issued to investors on ...

Truist lowered the firm’s price target on Biote (BTMD) to $7 from $9 and keeps a Buy rating on the shares. The company’s Q4 was a challenging quarter and its introduced below-Street guidance ...

biote Corp. (NASDAQ:BTMD – Free Report) – Analysts at Roth Capital dropped their Q1 2025 earnings per share (EPS) estimates for biote in a research note issued to investors on Thursday, March ...

Good day and welcome to the Biote fourth quarter 2024 earnings conference call. (Operator Instructions) Please note that this event is being recorded. I would now like to turn the conference over to ...

Despite the earnings miss and soft guidance, Biote reported a full-year revenue increase of 6.4% to $197.2 million in 2024. The company’s gross profit margin improved to 70.5% from 68.8% in the ...

Truist Financial analyst Les Sulewski maintained a Buy rating on biote (BTMD – Research Report) today and set a price target of $7.00. The company’s shares closed yesterday at $4.10.